Abstract

Bronchopulmonary dysplasia (BPD) is a chronic lung disease primarily affecting premature infants who require oxygen therapy. It results from damaged lung tissue, which leads to inflammation and impaired respiratory function. This study aims to explore the pathophysiology of BPD, its clinical manifestations, and the long-term respiratory outcomes in affected neonates. By examining recent advancements in treatment and management strategies, we aim to provide a comprehensive understanding of the impact of BPD on the respiratory health of premature infants.